quinidine has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, K; Ahmad, SS; Alam, Q; Alnamshan, MM; Alqosaibi, AI; Alshamrani, S; Bahnass, MM; Beg, MMA; Chaturvedi, N; Mashraqi, MM; Mishra, A; Rizvi, SMD; Shaikh, S | 1 |
| Bloomgarden, ZT | 1 |
2 other study(ies) available for quinidine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Biocomputational Prediction Approach Targeting FimH by Natural SGLT2 Inhibitors: A Possible Way to Overcome the Uropathogenic Effect of SGLT2 Inhibitor Drugs.
Topics: Adhesins, Escherichia coli; Computational Biology; Computer Simulation; Coumarins; Diabetes Mellitus, Type 2; Escherichia coli Infections; Fimbriae Proteins; Humans; Isoflavones; Molecular Docking Simulation; Quinidine; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Urinary Tract Infections; Uropathogenic Escherichia coli | 2021 |
Is glycemic control a quinidine-like intervention?
Topics: Biomarkers; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Evidence-Based Medicine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Patient Selection; Quinidine; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2014 |